Index Trends And Stocks In Action September 04, 2015
Chirag Gothi / 04 Sep 2015

The Indian market snapped its three day losing streak on the back of positive cues from global market. Technically, the index opened with a gap up and started to move up soon after the opening.
The Indian market snapped its three day losing streak on the back of positive cues from global market. Technically, the index opened with a gap up and started to move up soon after the opening. However, a dip was seen in the afternoon session and this dip was used by traders to initiative long position. On the daily chart the index has formed a perfect Bullish Harami candlestick pattern, this act as reversal candlestick after a sharp decline. However, confirmation is required on the next day for the validation of pattern. Now going forward the level of 7865 is a hurdle for the index on the upside. On the downside important support for the index is around 7740.
Ashok Leyland: RBI has allowed foreign investors to invest up to 40 per cent of the paid up capital in Ashok Leyland.
Raymond: Suiting fabric producer Raymond said it plans to invest $5 million to launch its products in the West Asian and African markets through its subsidiaries
Cipla: India's third-largest drug maker Cipla is buying the American business of Hyderabad-based Hetero Drugs as it seeks to expand its fledgling presence in the world's biggest pharma market.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.